Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of the Ability of a Flu Vaccine to Prevent Flu Infection
- Status
- COMPLETED
- Phase
- PHASE1
Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants
- Status
- COMPLETED
- Phase
- PHASE3
Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
- Status
- WITHDRAWN
- Phase
- PHASE2
T and B Cell Response to Avian Flu Vaccine
- Status
- COMPLETED
- Phase
- N/A
Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pharma-Pen (Formerly Innoject) Auto-injectory TIV
- Status
- WITHDRAWN
- Phase
- PHASE1
Alternative Oseltamivir Dosing Strategies
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate an Influenza Vaccine Candidate
- Status
- COMPLETED
- Phase
- PHASE2